Page 29 - Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CARA Cara Therapeutics	US$0.36	-2.3%	-89.2%	US$20.4m	US$1.52	PS1.2x	E25.3%	n/a
FBRX Forte Biosciences	US$0.56	-1.6%	-45.2%	US$20.3m	US$3.38	PB0.7x	S90.5%	n/a
AIM AIM ImmunoTech	US$0.35	-6.5%	-44.6%	US$20.3m	US$3.58	PS105.1x	E2.7%	n/a
VINC Vincerx Pharma	US$0.65	-0.8%	-39.8%	US$20.2m	US$7.00	PE-0.5x	E10.2%	n/a
APM Aptorum Group	US$3.49	1.5%	74.5%	US$19.9m	n/a	PS44.3x	n/a	n/a
SYBX Synlogic	US$1.69	3.0%	-77.0%	US$19.6m	US$1.00	PS6.2x	E81.8%	n/a
CBIO Catalyst Biosciences	US$7.67	18.6%	-8.4%	US$19.4m	n/a	PE-0.4x	E75.6%	n/a
IBIO iBio	US$2.13	-3.7%	-78.9%	US$19.4m	US$4.30	PS367x	S61.3%	n/a
OMIC Singular Genomics Systems	US$7.78	-4.0%	-67.3%	US$19.3m	US$6.50	PS7.7x	E5.5%	n/a
VIRX Viracta Therapeutics	US$0.48	-3.6%	-69.2%	US$18.9m	US$5.00	PB3.4x	E-0.9%	n/a
LYRA Lyra Therapeutics	US$0.33	13.8%	-89.8%	US$18.8m	US$4.50	PS11.9x	E0.4%	n/a
CDT Conduit Pharmaceuticals	US$0.23	-1.9%	-97.8%	US$18.1m	n/a	PE-7.1x	n/a	n/a
CMMB Chemomab Therapeutics	US$1.18	1.7%	-7.8%	US$18.1m	US$8.67	PB1.3x	E-14.8%	n/a
INDP Indaptus Therapeutics	US$2.05	-6.0%	-1.0%	US$17.5m	US$10.00	PB1.9x	E13.5%	n/a
EDSA Edesa Biotech	US$5.20	12.3%	-9.4%	US$17.4m	US$20.50	PB3.9x	E-26.2%	n/a
UNCY Unicycive Therapeutics	US$0.42	4.7%	-63.7%	US$17.2m	US$5.75	PE-0.4x	E53.7%	n/a
PMCB PharmaCyte Biotech	US$2.00	-0.5%	-24.8%	US$16.7m	n/a	PB0.5x	n/a	n/a
PYPD PolyPid	US$3.45	0.06%	-68.0%	US$16.6m	US$12.33	PB2.3x	E-1.1%	n/a
SNSE Sensei Biotherapeutics	US$0.69	2.4%	-45.6%	US$16.6m	US$4.25	PB0.3x	E-18.2%	n/a
EVAX Evaxion Biotech	US$3.03	9.6%	-75.6%	US$16.2m	US$11.75	PS132x	E62.5%	n/a
AYTU Aytu BioPharma	US$2.68	-2.7%	48.1%	US$16.1m	US$8.00	PB0.5x	E96.2%	n/a
VBIV VBI Vaccines	US$0.56	-11.7%	-57.5%	US$16.1m	US$5.00	PS1.7x	E66.2%	n/a
GLYC GlycoMimetics	US$0.23	-28.0%	-85.8%	US$15.5m	n/a	PS1503.3x	E-12.3%	n/a
GLTO Galecto	US$0.56	5.7%	-81.8%	US$15.5m	US$5.50	PB0.5x	E-18.1%	n/a